CRISPR/cas9 endonuclease-mediated genome editing is used to create an amino acid substitution at position 240 (arginine to termination codon, R240X). Loss of function mutations in laforin, such as R241X (corresponding to mouse R240X), are associated with Lafora disease, a rare and severe form of progressive myoclonus epilepsy. (J:335247)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count